Posts
October 24 2017
Synthesis Energy Systems Inc. announced the closing of their PIPE offering in the amount of $15,000,000. EG&S acted as counsel to the Lead Investor.
October 23 2017
Immune Pharmaceuticals Inc., a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, announced the closing of an underwritten public offering in the amount of $18,000,000. The offering was comprised of Series E Convertible Preferred Stock and warrants. EG&S acted as counsel to Maxim Group LLC, the sole book-running manager in the offering.
October 23 2017
Bloomberg published an article titled “2017 IPOs Are Larger and Faster” which analyzes the IPO market activity for the first three quarters of 2017. In the Diversified sector, Ellenoff Grossman & Schole led with 11 IPOs that raised a total of $2.10 billion, but Weil Gotshal & Manges participated in six IPOs that totaled $3.55 billion. Venable led the Financial sector with seven IPOs that raised a total of $2.76 billion. The Industrial sector was dominated by Latham & Watkins and Simpson Thacher & Bartlett, while the Technology sector was led by Wilson Sonsini Goodrich & Rosati.
Click here to read the full article.
October 20 2017
Connekt Media Inc. announced the closing of their bridge loan in the amount of $2,000,000. EG&S acted as counsel to the Investor.
October 17 2017
CASI Pharmaceuticals Inc. announced the closing of their Registered Direct offerings in the amount of $23,855,595. EG&S acted as counsel to the Placement Agent.
October 13 2017
Intellipharmaceutics International Inc. announced the closing of their Registered Direct offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
October 12 2017
Cellectar Biosciences Inc. announced the closing of their Registered Direct offering in the amount of $7,766,164. EG&S acted as counsel to the Placement Agent.
October 11 2017
Rimini Street, Inc., a global provider of enterprise software products and services, announced the closing of its merger with special purpose acquisition company GP Investments Acquisition Corp. The combined company will retain the Rimini Street, Inc. name and will trade on Nasdaq as “RMNI.” The transaction was valued at $50,000,000. Cowen served as financial and capital markets advisor to Rimini Street, and EG&S acted as counsel to Cowen.